{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:20:00Z","timestamp":1791566400045,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,8]],"date-time":"2027-06-08T00:00:00Z","timestamp":1812412800000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018047","name":"NRG Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017788","name":"ECOG-ACRIN Cancer Research Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017788","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijrobp.2026.02.201","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:23:31Z","timestamp":1771374211000},"page":"714-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incorporating Intensity Modulated Total Body Irradiation (IMRT-TBI) Into Future Cooperative Group Clinical Trials: An NRG Hematologic Malignancies Working Group-Led Report From the National Clinical Trials Network"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2619-7262","authenticated-orcid":false,"given":"Nataliya","family":"Kovalchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Simiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"LaRiviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Hiniker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Soike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Dandapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Teruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naamit K.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheen","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze Y.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kujtim","family":"Latifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas B.","family":"Figura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak K.","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Grecula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin J.","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koren","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Plastaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford S.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Milgrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.02.201_bib0001","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","article-title":"A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplantation Group","volume":"83","author":"Ringd\u00e9n","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0002","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0360-3016(94)00335-I","article-title":"Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia","volume":"31","author":"Dusenbery","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0003","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood.V97.11.3669","volume":"97","author":"Blaise","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0004","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.bmt.1701334","article-title":"Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan\/cyclophosphamide vs total body irradiation: A meta-analysis","volume":"22","author":"Hartman","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0005","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: Working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0006","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00066-021-01810-4","article-title":"Total body irradiation as part of conditioning regimens in childhood leukemia\u2014Long-term outcome, toxicity, and secondary malignancies","volume":"198","author":"Gruen","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0007","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood.2018874115","article-title":"Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation","volume":"133","author":"Baker","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30589","article-title":"Improved organ sparing using auto-planned Stanford volumetric modulated arc therapy for total body irradiation technique","volume":"70","author":"Ngo","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0009","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.prro.2021.12.007","article-title":"The Stanford volumetric modulated arc therapy total body irradiation technique","volume":"12","author":"Kovalchuk","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semradonc.2024.10.003","article-title":"Radiation as an immune modulator: Where we are with modern total body irradiation","volume":"35","author":"Simiele","year":"2025","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0011","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/bmt.2010.237","article-title":"Clinical feasibility of TBI with helical tomotherapy","volume":"46","author":"Pe\u00f1agar\u00edcano","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0012","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1748-717X-8-92","article-title":"Total body irradiation (TBI) using Helical Tomotherapy in children and young adults undergoing stem cell transplantation","volume":"8","author":"Gruen","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0013","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13014-016-0625-7","article-title":"Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience","volume":"11","author":"Springer","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0014","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.radonc.2018.08.005","article-title":"Total-body irradiation using linac-based volumetric modulated arc therapy: Its clinical accuracy, feasibility and reliability","volume":"129","author":"Tas","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41409-017-0049-5","article-title":"Haploidentical hematopoietic SCT using helical tomotherapy for total-body irradiation and targeted dose boost in patients with high-risk\/refractory acute lymphoblastic leukemia","volume":"53","author":"Jiang","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0016","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/jrr\/rraa078","article-title":"Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: A prospective pilot study","volume":"61","author":"Konishi","year":"2020","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.10.020","article-title":"Volumetric modulated arc therapy enabled total body irradiation (VMAT-TBI): Six-year clinical experience and treatment outcomes","volume":"28","author":"Zhang-Velten","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0018","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29689","article-title":"Volumetric modulated arc therapy total body irradiation in pediatric and adolescent\/young adult patients undergoing stem cell transplantation: Early outcomes and toxicities","volume":"69","author":"Marquez","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1044539","article-title":"Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy","volume":"12","author":"Ladbury","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0020","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231180779","article-title":"Feasibility and toxicity of full-body volumetric modulated arc therapy technique for high-dose total body irradiation","volume":"22","author":"Keit","year":"2023","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0021","article-title":"Acute toxicity of total body irradiation using volumetric arc therapy with a focus on the effect of lung dose rate","volume":"9","author":"Melton","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1459287","article-title":"Volumetric modulated arc therapy total body irradiation improves toxicity outcomes compared to 2D total body irradiation","volume":"14","author":"Hui","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.785916","article-title":"Optimized conformal total body irradiation among recipients of TCR\u03b1\u03b2\/CD19-depleted grafts in pediatric patients with hematologic malignancies: Single-center experience","volume":"11","author":"Kobyzeva","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0024","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.phro.2017.11.002","article-title":"Volumetric modulated arc therapy based total body irradiation: Workflow and clinical experience with an indexed rotational immobilization system","volume":"4","author":"Ouyang","year":"2017","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0025","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13014-019-1445-3","article-title":"Novel rotatable tabletop for total-body irradiation using a linac-based VMAT technique","volume":"14","author":"Losert","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0026","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/acm2.13412","article-title":"Image-guided volumetric-modulated arc therapy of total body irradiation: An efficient workflow from simulation to delivery","volume":"22","author":"Guo","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0027","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/acm2.13189","article-title":"Automatic treatment planning for VMAT-based total body irradiation using Eclipse scripting","volume":"22","author":"Teruel","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0028","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.meddos.2009.07.001","article-title":"Dosimetric study and verification of total body irradiation using helical tomotherapy and its comparison to extended SSD technique","volume":"35","author":"Zhuang","year":"2010","journal-title":"Med Dosim"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0029","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/acm2.12257","article-title":"Volumetric modulated arc therapy for total body irradiation: A feasibility study using Pinnacle3 treatment planning system and Elekta Agility\u2122 linac","volume":"19","author":"Symons","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110366","article-title":"Technical recommendations for implementation of volumetric modulated arc therapy and helical tomotherapy total body irradiation","volume":"197","author":"Seravalli","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31185","article-title":"Incorporating intensity modulated total body irradiation into a Children's Oncology Group trial: Rationale, techniques, and safeguards","volume":"71","author":"Milgrom","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0032","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/COC.0000000000000997","article-title":"ACR-ARS practice parameter for the performance of total body irradiation","volume":"46","author":"Reilly","year":"2023","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0033","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.soc.2023.03.001","article-title":"Modern radiation for hematologic stem cell transplantation: Total marrow and lymphoid irradiation or intensity-modulated radiation therapy total body irradiation","volume":"32","author":"Hao","year":"2023","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0034","article-title":"Considerations for intensity modulated total body or total marrow and lymphoid irradiation","volume":"43","author":"Parsons","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0035","series-title":"TBI using IMRT (VMAT or tomotherapy) for the prevention of pul toxicities in patients undergoing donor SCT","year":"2025"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.970425","article-title":"Auto-segmentation for total marrow irradiation","volume":"12","author":"Watkins","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1378449","article-title":"Automated contouring, treatment planning, and quality assurance for VMAT craniospinal irradiation (VMAT-CSI)","volume":"14","author":"Simiele","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.785917","article-title":"Optimized conformal total body irradiation methods with helical tomotherapy and Elekta VMAT: Implementation, Imaging, planning and dose delivery for pediatric patients","volume":"12","author":"Loginova","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0039","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1118\/1.1896453","article-title":"The helical tomotherapy thread effect","volume":"32","author":"Kissick","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0040","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1118\/1.3644842","article-title":"Theoretical analysis of the thread effect in helical TomoTherapy","volume":"38","author":"Chen","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0041","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ijrobp.2013.07.017","article-title":"Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy","volume":"87","author":"Takahashi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0042","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1120\/jacmp.v16i5.5282","article-title":"Effects of changing modulation and pitch parameters on tomotherapy delivery quality assurance plans","volume":"16","author":"Binny","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0043","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1120\/jacmp.v16i6.5580","article-title":"Virtual bolus for total body irradiation treated with helical tomotherapy","volume":"16","author":"Moliner","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0044","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.prro.2021.02.010","article-title":"A step toward making VMAT TBI more prevalent: Automating the treatment planning process","volume":"11","author":"Simiele","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0045","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijrobp.2019.02.034","article-title":"Higher reported lung dose received during total body irradiation for allogeneic hematopoietic stem cell transplantation in children with acute lymphoblastic leukemia is associated with inferior survival: A report from the Children's Oncology Group","volume":"104","author":"Esiashvili","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0046","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ijrobp.2019.08.010","article-title":"Radiation-related toxicities using organ sparing total marrow irradiation transplant conditioning regimens","volume":"105","author":"Shinde","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0047","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2014.3","article-title":"Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: An LEA study","volume":"49","author":"Bernard","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0048","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00066-006-1528-6","article-title":"Biologically effective dose in total-body irradiation and hematopoietic stem cell transplantation","volume":"182","author":"Kal","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0049","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0360-3016(01)02758-4","article-title":"Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia","volume":"52","author":"van Kempen-Harteveld","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0050","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1002\/mp.12810","article-title":"Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218","volume":"45","author":"Miften","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0051","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1002\/mp.14030","article-title":"Strategies for effective physics plan and chart review in radiation therapy: Report of AAPM Task Group 275","volume":"47","author":"Ford","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0052","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1118\/1.4947547","article-title":"The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management","volume":"43","author":"Huq","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0053","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13014-021-01894-3","article-title":"A bi-institutional multi-disciplinary failure mode and effects analysis (FMEA) for a Co-60 based total body irradiation technique","volume":"16","author":"Ahmed","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0054","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1002\/mp.16466","article-title":"Implementing failure mode and effect analysis to improve the safety of volumetric modulated arc therapy for total body irradiation","volume":"50","author":"Gray","year":"2023","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13014-019-1433-7","article-title":"Evaluation and improvement the safety of total marrow irradiation with helical tomotherapy using repeat failure mode and effects analysis","volume":"14","author":"Shen","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0056","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0020-708X(60)90111-3","article-title":"A total body irradiation chamber and its uses","volume":"8","author":"Jacobs","year":"1960","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0057","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1148\/72.2.266","article-title":"Development of a room specifically designed for total-body irradiation","volume":"72","author":"Sahler","year":"1959","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0058","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0360-3016(80)90240-0","article-title":"A report of the work party: Comparison of total body irradiation techniques for bone marrow transplantation","volume":"6","author":"Kim","year":"1980","journal-title":"Int J Radiat Oncol Biol Phys. 1980"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0059","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0167-8140(85)80122-5","article-title":"Effect of dose-rate on total body irradiation: Lethality and pathologic findings","volume":"4","author":"Travis","year":"1985","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7326\/0003-4819-104-2-168","article-title":"Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors","volume":"104","author":"Weiner","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-8140(90)90161-O","article-title":"Radiobiological aspects of continuous low dose-rate irradiation and fractionated high dose-rate irradiation","volume":"19","author":"Turesson","year":"1990","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0062","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0360-3016(91)90314-T","article-title":"The dose-rate effect revisited: Radiobiological considerations of importance in radiotherapy","volume":"21","author":"Hall","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ijrobp.2026.02.201_bib0063","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0360-3016(80)90241-2","article-title":"Discussion: The radiobiological bases of TBI","volume":"6","author":"Peters","year":"1980","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0064","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1148\/131.1.243","article-title":"Radiobiological considerations in the use of total-body irradiation for bone-marrow transplantation","volume":"131","author":"Peters","year":"1979","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0065","series-title":"Biological effects of protracted exposure to ionizing radiation: Review, analysis, and model development","year":"1991"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0066","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ijrobp.2023.02.037","article-title":"Idiopathic pneumonitis syndrome after total body irradiation in pediatric patients undergoing myeloablative hematopoietic stem cell transplantation: A PENTEC comprehensive review","volume":"119","author":"Ehler","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0067","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2005.02.032","article-title":"Dose response and factors related to interstitial pneumonitis after bone marrow transplant","volume":"63","author":"Sampath","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0068","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0360-3016(87)90046-0","article-title":"Fractionation and dose rate effects in mice: A model for bone marrow transplantation in man","volume":"13","author":"Tarbell","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0069","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/1097-0142(19920601)69:11<2853::AID-CNCR2820691135>3.0.CO;2-2","article-title":"Total-body irradiation before bone marrow transplantation. Results of two randomized instantaneous dose rates in 157 patients","volume":"69","author":"Ozsahin","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13566-019-00374-2","article-title":"Reduced acute and late toxicities with intensity-modulated radiation therapy compared to three-dimensional conformal radiation therapy in post-operative gastric cancer","volume":"8","author":"Shinde","year":"2019","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0071","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1016\/j.ijrobp.2024.07.2216","article-title":"Radiation-related late toxicities following total marrow irradiation transplant conditioning regimens","volume":"120","author":"Ladbury","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0072","series-title":"Presented at: American Society of Hematology Meeting","article-title":"Phase I-II trial of tandem autologous transplantation with melphalan followed by total marrow irradiation ablative therapy in patients with responding or stable multiple myeloma","author":"Somlo","year":"2012"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0073","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2017.01.067","article-title":"Phase I trial of total marrow and lymphoid irradiation transplantation conditioning in patients with relapsed\/refractory acute leukemia","volume":"23","author":"Stein","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0074","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1182\/bloodadvances.2022007264","article-title":"Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide","volume":"6","author":"Al Malki","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0075","article-title":"Total marrow and lymphoid irradiation with post-transplantation cyclophosphamide for patients with AML in remission","volume":"22","author":"Stein","year":"2022","journal-title":"Transpl Cell Ther. 2022"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0076","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2010-06-288357","article-title":"Phase 1\/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies","volume":"117","author":"Rosenthal","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0077","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1003908","article-title":"Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - A single institution experience review","volume":"12","author":"Wong","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0078","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/s41409-020-01181-x","article-title":"Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma","volume":"56","author":"Giebel","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0079","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ejh.13675","article-title":"Organ sparing total marrow irradiation compared to total body irradiation prior to allogeneic stem cell transplantation","volume":"107","author":"Haraldsson","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0080","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/cas.15611","article-title":"Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemia","volume":"114","author":"Ogawa","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0081","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.bbmt.2017.04.002","article-title":"Dose escalation of total marrow irradiation in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Hui","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0082","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/bloodadvances.2022007530","article-title":"A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT","volume":"7","author":"Tran","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0083","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1080\/10428194.2017.1390231","article-title":"A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200\u2009mg\/m2 and total marrow irradiation (TMI) in patients with relapsed\/refractory multiple myeloma","volume":"59","author":"Patel","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0084","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/bloodadvances.2020003739","article-title":"Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia","volume":"5","author":"Pierini","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0085","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.bbmt.2014.09.005","article-title":"Combination of linear accelerator\u2013based intensity-modulated total marrow irradiation and myeloablative fludarabine\/busulfan: A phase I study","volume":"20","author":"Patel","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0086","article-title":"Treatment robustness of total body irradiation with volumetric modulated arc therapy","volume":"29","author":"Seravalli","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0087","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1016\/j.prro.2022.05.003","article-title":"Pulmonary toxic effects after myeloablative conditioning with total body irradiation delivered via volumetric modulated arc therapy with fludarabine","volume":"12","author":"Modrek","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0088","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1118\/1.3495816","article-title":"Statistical analysis of dose heterogeneity in circulating blood: Implications for sequential methods of total body irradiation","volume":"37","author":"Molloy","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0089","unstructured":"Guo B. Dose to circulating blood in intensity-modulated total body irradiation, total marrow irradiation, and total marrow and lymphoid irradiation using realistic whole-body blood circulation modeling. Presented at: AAPM 2024. 66th Annual Meeting & Exhibition; July 21-25; Los Angeles, CA. https:\/\/aapm.confex.com\/aapm\/2024am\/meetingapp.cgi\/Paper\/9211. Accessed March 10, 2026."},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0090","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0091","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/blood.V77.8.1660.1660","article-title":"Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens","volume":"77","author":"Clift","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0092","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.V92.4.1455","article-title":"Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia","volume":"92","author":"Clift","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0093","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1118\/1.2044428","article-title":"Feasibility study of helical tomotherapy for total body or total marrow irradiation","volume":"32","author":"Hui","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0094","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ijrobp.2006.10.047","article-title":"Image-guided total marrow and total lymphatic irradiation using helical tomotherapy","volume":"67","author":"Schultheiss","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0095","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijrobp.2012.03.033","article-title":"Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"85","author":"Wong","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.04.001","article-title":"Targeted marrow irradiation intensification of reduced-intensity fludarabine\/busulfan conditioning for allogeneic hematopoietic stem cell transplantation","volume":"28","author":"Ali","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0097","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbmt.2017.09.019","article-title":"Total marrow lymphoid irradiation\/fludarabine\/melphalan conditioning for allogeneic hematopoietic cell transplantation","volume":"24","author":"Jensen","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0098","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.radonc.2011.01.016","article-title":"Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant","volume":"98","author":"Corv\u00f2","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0099","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/S1470-2045(20)30342-9","article-title":"Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia","volume":"21","author":"Wong","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0100","series-title":"Gunderson & Tepper\u2019s Clinical Radiation Oncology","article-title":"Total body irradiation","author":"Imber","year":"2024"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0101","series-title":"Perez & Brady's Principles and Practice of Radiation Oncology","article-title":"Stem cell transplantation and radiation therapy techniques","author":"Kelsey","year":"2024"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2023.04.014","article-title":"Total marrow irradiation for second allogeneic hematopoietic stem cell transplantation in patients with advanced acute leukemia","volume":"29","author":"Dominietto","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.ijrobp.2026.02.201_bib0103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijrobp.2014.01.036","article-title":"Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation","volume":"89","author":"Kim","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626003883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626003883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T12:30:56Z","timestamp":1784982656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626003883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":103,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0360301626003883"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.201","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporating Intensity Modulated Total Body Irradiation (IMRT-TBI) Into Future Cooperative Group Clinical Trials: An NRG Hematologic Malignancies Working Group-Led Report From the National Clinical Trials Network","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}